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The relationship between human cytomegalovirus (HCMV) infections and accelerated 
immune senescence is controversial. Whereas some studies reported a CMV-associated 
impaired capacity to control heterologous infections at old age, other studies could not 
confirm this. We hypothesized that these discrepancies might relate to the variability in 
the infectious dose of CMV occurring in real life. Here, we investigated the influence of 
persistent CMV infection on immune perturbations and specifically addressed the role of 
the infectious dose on the contribution of CMV to accelerated immune senescence. We 
show in experimental mouse models that the degree of mouse CMV (MCMV)-specific 
memory CD8+ T cell accumulation and the phenotypic T cell profile are directly influenced 
by the infectious dose, and data on HCMV-specific T cells indicate a similar connection. 
Detailed cluster analysis of the memory CD8+ T cell development showed that high-dose 
infection causes a differentiation pathway that progresses faster throughout the life span of 
the host, suggesting a virus–host balance that is influenced by aging and infectious dose. 
Importantly, short-term MCMV infection in adult mice is not disadvantageous for heterol-
ogous superinfection with lymphocytic choriomeningitis virus (LCMV). However, following 
long-term CMV infection the strength of the CD8+ T cell immunity to LCMV superinfection 
was affected by the initial CMV infectious dose, wherein a high infectious dose was found 
to be a prerequisite for impaired heterologous immunity. Altogether our results underscore 
the importance of stratification based on the size and differentiation of the CMV-specific 
memory T cell pools for the impact on immune senescence, and indicate that reduction of 
the latent/lytic viral load can be beneficial to diminish CMV-associated immune senescence.
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inTrODUcTiOn
Age-related decline in immunological competence, often referred to as immune senescence, is 
associated with an increased incidence of cancer, infections, and a reduced efficacy of vaccines 
(1). Factors thought to contribute to this progressive decline of immune responses include genetic, 
molecular, and cellular defects, but also environmental stressors such as chronic infections.
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Human cytomegalovirus (HCMV), a member of the betaher-
pesvirus family, persists in the majority of the adult population 
(2). Compared to other infections, extraordinary high memory 
T cell frequencies, on average ~10% of the total memory T cell 
compartment, are noticed in peripheral blood of healthy indi-
viduals (3). Especially at old age, it has been observed that the 
HCMV-specific memory T cell pool can even occupy up to 50% 
of the total memory compartment (4). This phenomenon of high 
frequencies of circulating memory T  cells that are maintained 
during the lifespan of the host or even can undergo gradual 
increment, aptly named memory inflation (5), is characteristic 
of CMV infection in general, as this is also found upon infection 
with the related mouse CMV (MCMV) and Rhesus Macaque 
CMV (RhCMV) [reviewed in Ref. (6, 7)]. The inflationary 
T cells, which increase in numbers during the persistent phase 
of infection, are phenotypically characterized by an “effector-
memory (EM)”-like appearance (CD27low/CD62Llow/CD127−/
KLRG1+; e.g., the CD8+ T cell response against the m139419–426, 
M38316–323, IE3416–423 epitopes in MCMV). During CMV infection, 
T cells with a central-memory phenotype also exist (CD27high/
CD62Lhigh/CD127+), which peak early during infection, con-
tract, and establish stable memory pools (e.g., the CD8+ T cell 
response against the M45985–993 epitope in MCMV). The occur-
rence of inflationary T cell responses is reliant on the intermit-
tent transcription of CMV during latency resulting in antigen 
reactivation (8). In addition, the efficacy of peptide processing 
by the constitutive proteasome is an important determinant for 
memory inflation (9).
Epidemiological studies have shown an association between 
HCMV positivity and manifestations of immune senescence 
by linking persistent HCMV infection to decreased overall 
survival in the elderly and to the immune risk profile (IRP), 
a cluster of parameters predictive for 2-year mortality in the 
elderly (10, 11). In addition, anti-HCMV IgG titers in aged 
individuals have been correlated with lower antibody responses 
to influenza (12–15); however, other studies could not confirm 
this finding (16–19). Thus, whether HCMV infection is caus-
ally linked with accelerated immune senescence is a topic of 
debate (20, 21).
To gain more insight into the possible connection between 
CMV infection and immune senescence, mouse studies have 
been performed previously in which it was demonstrated that 
long-term CMV infection impairs newly generated CD8+ T cell 
responses to heterologous infections (22–24). However, these 
studies have been conducted using relatively high doses of 
virus, and have not taken into account the variability in real life 
with respect to the infectious dose. For example, in the human 
population the percentages of CMV-specific T cells occupying 
the memory T cell compartment is highly variable (ranging from 
0.01 to 50%) (3), which is likely related to the significant differ-
ence in the quantity of CMV found in bodily fluids, such as breast 
milk, saliva, and urine (101–105  copies/μl), causing horizontal 
transmission of CMV (25, 26). In this respect, we have previ-
ously shown that the degree of accumulation and phenotype of 
inflationary CMV-specific CD8+ T cells is corresponding to the 
size of the initial infectious dose (27).
We anticipate that the viral inoculum size is highly variable 
between individuals and that this accounts for the large variance 
in the frequency, phenotype, and accumulation of CMV-specific 
CD8+ memory T  cells in infected humans, which may be an 
explanation for the controversial results with respect to the possi-
ble contribution of CMV to immune senescence. Here, we tested 
this hypothesis in a highly controlled prospective study using the 
mouse model of CMV infection, which mimics CMV infection 
in humans (28). We inoculated mice with different inoculum dos-
ages of MCMV and investigated longitudinally the influence of 
lifelong CMV infection on alterations within the peripheral T cell 
pool. To specifically assess the role of the CMV inoculum size 
on the development of heterologous anti-viral immunity, aged 
MCMV-infected mice received a challenge with lymphocytic 
choriomeningitis virus (LCMV). Our results show that the viral 
inoculum size determines the degree of CMV-induced immune 
alterations in lifelong infection. Furthermore, we demonstrate 
that only infection caused by a high MCMV dose reduces newly 
generated CD8+ T cell responses to heterologous superinfection. 
To our knowledge, this is the first evidence that the inoculum size 
of CMV is a crucial determinant for the development of CMV-
associated impaired immunity in aging.
MaTerials anD MeThODs
Mice
Wild-type (WT) C57BL/6 mice were purchased from Charles 
River. All mice were maintained under specific pathogen-free 
conditions at the Central Animal Facility of LUMC. Mice were 
housed under 12  h light/dark cycle, feed ad  libitum and were 
7–10 weeks old at the beginning of each experiment.
Viruses
Mouse CMV-Smith was obtained from the American Type Culture 
Collection (ATCC VR-194; Manassas, VA, USA) and salivary 
gland stocks were prepared from infected BALB/c mice. WT mice 
matched for gender and age were infected i.p. with indicated dos-
ages of salivary gland derived MCMV-Smith. For weekly infec-
tions with MCMV mice received 5 × 104 PFU MCMV weekly for 
1 year. Vaccinia virus expressing IE1 of MCMV (VACV-IE1) was 
produced as described elsewhere (29). BALB/c × DBA/2 F1 mice 
were infected with 1 × 106 PFU (VACV-IE1) as described (23). 
LCMV-Armstrong was propagated on BHK cells and titers of 
virus stocks and organ homogenates were determined by plaque 
assays on Vero cells as described. For LCMV-Armstrong infec-
tion, WT mice (uninfected and previously infected with MCMV) 
were infected i.p. with 2 × 105 PFU. LCMV titers in the lungs and 
kidneys were determined by a virus focus forming assay on Vero 
76 cells as described elsewhere (30).
study subjects
For phenotypical analysis of HCMV-specific T  cell responses, 
PBMCs from HCMV-seropositive healthy donors and from 
initially HCMV-seronegative recipients (HLA-A*0101+, HLA-
A*0201+, HLA-B*0702+, HLA-B*3501+) receiving a HCMV-
positive kidney transplant were isolated and labeled for flow 
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cytometry analysis (31). Quantitative PCR for HCMV was 
performed in EDTA-treated whole-blood samples, as described 
elsewhere (32).
Flow cytometry
MHC class I tetramer staining combined with phenotyping, and 
intracellular cytokine staining were performed to determine the 
magnitude and characteristics of the mouse viral-specific T cell 
responses as described (33). Single-cell suspensions were prepared 
from spleens obtained from uninfected and infected mice by 
mincing the tissue through a 70-µm cell strainer (BD Bioscience). 
Blood was collected from the tail vein. Erythrocytes were lysed 
in a hypotonic ammonium chloride buffer. Fluorochrome-
conjugated antibodies specific for mouse CD3, CD4, CD8, CD27, 
CD44, CD62L, CD127 (IL-7Rα), IFN-γ, IL-2, KLRG1, and TNF 
were purchased from BD Biosciences, Biolegend, or eBioscience. 
Analysis of human PBMCs was performed as described (31). 
Fluorochrome-conjugated antibodies specific for human CCR7, 
CD3, CD8, CD27, CD28, CD45RA, CD57, CD127, and KLRG1 
were purchased from BD Biosciences, Biolegend, or eBioscience. 
Cells were acquired using a BD LSR Fortessa flow cytometer, 
and data were analyzed using FlowJo software (TreeStar) and 
Cytosplore (34). Dead cells were excluded using live/dead mark-
ers. Gating strategies were performed as described (27, 31).
Mhc class i Tetramers and  
synthetic Peptides
The following class I-restricted peptides were used: M45985–993, 
m139419–426, M38316–323, IE3416–423, IE1168–176 (MCMV), GP3333–41, 
NP396–404, GP276–286 (LCMV). A pool of the following class 
II-restricted MCMV peptides were used: M09133–147, M25409–423, 
m139560–574, and m14224–38 (35). The following class II-restricted 
LCMV peptide was used: GP61–80. APC and PE-labeled MHC class 
I tetrameric complexes with the above-described peptide epitopes 
were used. For analysis of HCMV-specific CD8+ T cell responses, 
MHC class I tetrameric complexes with the following peptides 
were used: pp65363–373 (HLA-A*0101), pp65495–503 (HLA-A*0201), 
pp65417–426 (HLA-B*0702), pp65123–131 (HLA-B*3501).
Multiplex
Blood was collected retro-orbitally and clotted for 30 min. After 
centrifugation, serum was collected and stored at −80°C until 
further use. Cytokines were measured in serum using a mouse 
Bio-Plex Pro Mouse Cytokine 23-plex immunoassay (Bio-Rad, 
Herculus, CA, USA) according to manufacturer’s protocol.
serum antibody Detection by elisa
Total IgM and IgG concentrations were determined by ELISA in 
serum samples as described earlier (27). Briefly, Nunc-Immuno 
Maxisorp plates (Fisher Scientific) were coated overnight with 
virus in bicarbonate buffer, and after blocking (skim milk 
powder, Fluka BioChemika), sera from mice were added. Next, 
plates were incubated with various HRP-conjugated antibodies 
(SouthernBiotech) to detect IgM/IgG. Plates were developed 
with TMB substrate (Sigma Aldrich), and the color reaction was 
stopped by the addition of 1 M H2SO4. Optical density was read at 
450 nm (OD450) using a Microplate reader (Model 680, Bio-Rad).
statistical analysis
To determine statistical significance between two groups, an 
unpaired Student’s t-test was performed. Significance between 
more than two groups was evaluated by one-way ANOVA and 
Tukey’s post hoc test was performed to correct for multiple com-
parisons. Mann–Whitney U test and Kruskal-Wallis test were 
performed to determine statistical differences in the viral load in 
mice. To test the strength of the linear relationship between the 
frequency of EM CD8+ T cells and the LCMV viral load, Pearson 
correlation was used. For correlations between the frequency of 
EM CD8+ T cells and the magnitude of the response, Spearman 
correlation was used. GraphPad Prism 6.0 software (GraphPad 
Software, La Jolla, CA, USA) was used for statistical analyses.
resUlTs
Disparate effects of cMV infection  
and aging on naive and Memory cD8+  
and cD4+ T cell subsets
To investigate whether dissimilar infectious dosages of MCMV 
differentially affect the immune system in lifelong infection, we 
inoculated C57BL/6 mice at 7 weeks of age with different dosages 
of MCMV-Smith (0, 103, 104, and 105 PFU) and monitored the 
CD4+ and CD8+ T cell frequencies over 300 days post-infection 
(dpi). In naive (uninfected) mice, the frequency of total periph-
eral CD8+ T cells was unchanged in time. However, early after 
MCMV infection (acute phase), CD8+ T  cell frequencies were 
elevated corresponding to the inoculum size (Figure  1A). 
A strict impact of the inoculum size was also observed at later 
time points: mice that were infected with the highest MCMV PFU 
quantities showed the highest frequency of CD8+ T cells. Only 
mice infected with the lowest inoculum dose (103 PFU) did not 
differ substantially during the persistent phase from naive age-
matched controls (Figure 1A). The frequency of total peripheral 
CD4+ T cells in naive and infected mice showed an age-related 
decrease, yet effects of the dosage of MCMV infection were not 
apparent for this T cell subset (Figure 1A).
It has been suggested that HCMV-seropositivity is linked to 
the IRP and one of the parameters defining the IRP is an inverted 
CD4/CD8 T  cell ratio (36). Moreover, it has been shown that 
latent MCMV infection decreases this ratio (23). By calculating, 
the CD4/CD8 T cell ratio, we also observed a decreased CD4/
CD8 T  cell ratio during the persistent phase and markedly 
noticed an obvious MCMV-dose impact for this phenomenon 
(Figure 1B). A decreased CD4/CD8 T cell ratio was also most 
apparent in high-dose-infected aged mice based on the absolute 
counts of CD8+ and CD4+ T cells present in the spleen, and this 
was mainly caused by an increment of the absolute CD8+ T cell 
count (Figure S1A in Supplementary Material).
Next, we assessed the influence of the different MCMV 
inoculum sizes on the naive and memory T cell subset composi-
tion during the course of infection. MCMV infection resulted in 
FigUre 1 | Disparate effects of CMV infection and aging on naive and memory CD8+ and CD4+ T cell subsets. Wild-type (WT) mice were infected with 103, 104, or 
105 PFU mouse CMV (MCMV)-Smith. (a) The average frequencies of CD8+ and CD4+ T cells in blood determined at the indicated time points post-infection. (B) The 
CD4+/CD8+ T cell ratio in blood determined at the indicated time points. (c) Representative flow cytometry plots showing the KLRG1 versus CD62L expression on 
CD8+ T cells of naive and 105 PFU MCMV-infected mice. (D) Kinetic analysis of the average frequencies of naive (CD44lowCD62L+KLRG1−) or effector-memory (Tem) 
(CD44highCD62L−KLRG1+) CD8+ and CD4+ T cells in blood. Error bars indicate SEM (n = 16 mice per group). Significance is indicated for day 300 post-infection. 
(*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001). Data were pooled from two independent experiments.
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strongly reduced frequencies of naive circulating CD8+ T cells 
(CD44lowCD62L+KLRG1−), which inversely correlated with the 
inoculum dose (Figures 1C,D). Aging reduced the naive CD8+ 
T  cell frequencies in both uninfected and infected mice. The 
differences between the groups of differently MCMV dosage 
inoculated mice remained over time. The naive CD4+ T  cell 
pool was not overtly influenced by the inoculum size or aging 
(Figure 1D).
Accumulation of EM (CD44highCD62L−KLRG1+) CD8+ 
T  cells was not observed in uninfected animals. However, this 
was clearly present after MCMV infection. Strikingly, increasing 
inoculum sizes correspondingly heightened the frequency of EM 
CD8+ T  cells. These differences in EM CD8+ T  cell frequency 
between the groups remained stable during persistent infection 
and somewhat inclined after 200 dpi (Figure 1D). The EM CD4+ 
T cell frequencies were increased after the highest dose inoculum 
and remained higher compared to lower dose infected mice and 
uninfected mice (Figure  1D). Aging increased the EM CD4+ 
T  cell frequency in both infected and uninfected mice after 
200 dpi. Thus, the size of the MCMV inoculum predominantly 
affects the formation of EM-like CD8+ T  cells throughout the 
course of infection while aging seems to predominantly impact 
the percentages of EM-like CD4+ T cells.
The Magnitude and Phenotype of 
inflationary McMV-specific cD8+  
T cells is strongly influenced by the 
inoculum Dose
Next, we determined if dissimilarities in inoculum dosage sizes 
would differentially affect MCMV-specific CD8+ T cell popula-
tions during aging. In the acute phase of infection, we observed 
that the magnitude of both non-inflationary (M45-specific) and 
inflationary (m139-, M38-, and IE3-specific) MCMV-specific 
CD8+ T cell responses were correspondingly ~2-fold higher in 
the group infected with a 10-fold higher dose. During the chronic 
phase of infection, the frequency of the M45-specific CD8+ 
T cells is comparable between the different inoculum sizes. By 
contrast, the magnitude of the CD8+ T cell response against the 
inflationary epitopes in m139, M38, and IE3 increased in a strict 
dose-dependent manner (Figure 2A).
Induction of MCMV-associated immune senescence may be 
potentiated by the accumulation of virus-specific EM-like CD8+ 
T cells. Here, we assessed the phenotype of the antigen-specific 
CD8+ T cells that were induced after inoculation with the differ-
ent MCMV doses. For all MCMV-specific CD8+ T cell responses 
measured, we observed that the size of the viral inoculum 
determines the frequency of effector CD8+ T  cells during the 
acute phase (Figure 2B). While the effector phenotypic profile 
of the non-inflationary M45-specific T cells is gradually turned 
into a predominant central-memory (CM; CD44highCD62L+ 
KLRG1−) phenotype, the CD8+ T cells that are specific for the 
inflationary epitopes exhibit an increased effector-type appear-
ance even after the acute phase of infection (Figure 2B; Figure 
S1B in Supplementary Material). The percentage of inflationary 
MCMV-specific CM CD8+ T cells is low throughout infection 
(Figure S1C in Supplementary Material). Thus, the initial 
infectious dose has a dominant influence and shapes both 
the magnitude and phenotype of inflationary MCMV-specific 
CD8+ T cells.
analogous correlations between the 
Magnitude and Phenotype of inflationary 
Mouse and human cMV-specific cD8+  
T cells
Subsequently, we evaluated whether correlations exist between 
the magnitude and phenotype of the CMV-specific CD8+ 
A
B
FigUre 2 | The magnitude and phenotype of inflationary mouse CMV (MCMV)-specific CD8+ T cells is strongly influenced by the inoculum dose. Wild-type (WT) 
mice were infected with 103, 104, or 105 PFU MCMV-Smith. (a) The average frequencies of MCMV-specific CD8+ T cells (i.e., specific to epitopes derived from the 
MCMV proteins M45, m139, M38, and IE3) in blood were determined by MHC class I tetramer staining at the indicated time points post-infection. Error bars 
indicate SEM (n = 16 mice per group). (B) Kinetic analysis of the average frequencies of EM (CD44highCD62L−KLRG1+) type CD8+ T cells within the total MCMV-
specific CD8+ T cell population in blood. Error bars indicate SEM (n = 16 mice per group). Significance is indicated for day 300 post-infection. (*P < 0.05; 
**P < 0.01; ***P < 0.001; ****P < 0.0001). Data were pooled from two independent experiments.
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T cells. Strikingly, only in case of responses against inflation-
ary epitopes, a direct correlation between the magnitude of 
the MCMV-specific CD8+ T  cell response and the frequency 
of the EM-like cells within the MCMV-specific CD8+ T  cell 
population is observed (Figure  3). In mice infected with the 
lowest dose (i.e., 1  ×  103 PFU), the magnitude of the CD8+ 
T  cell response against the inflationary epitopes and the fre-
quency of effector cells is correspondingly the lowest, whereas 
these are highest in infection with the highest dose (i.e., 1 × 105 
PFU) (Figure  3A). Also, when we inoculated mice weekly 
with the same dose of MCMV for a period of 1 year, we found 
these correlations between the magnitude and phenotype of 
the inflationary CD8+ T  cells, and these correlations were 
similar to those found in mice infected with MCMV once 
(Figure 3B). Responses against IE1 in the context of MCMV 
infection results in a similar correlation as observed for IE3 
(data not shown) while IE1 expressed by recombinant vaccinia 
virus (VACV-IE1), eliciting acute but not persistent infection, 
did not elicit EM phenotype versus magnitude correlations 
(Figure 3C), Moreover, the IE1-specific CD8+ T cell response 
elicited by VACV-IE1 is with respect to the magnitude and 
EM kinetics similar to the M45-specific response elicited by 
high-dose MCMV [(23) and data not shown]. Together, these 
results indicate that viral antigen reactivation is essential for 
the observed correlations between the magnitude and EM 
phenotype of the CD8+ T cells.
Since humans are likely infected with varying doses of 
HCMV, we aimed to recapitulate whether the above-described 
correlations also exist in HCMV-positive individuals. Therefore, 
we performed analysis of the human pp65-specific CD8+ T cell 
response in a large cohort of healthy HCMV-seropositive 
individuals. Essentially, reminiscent to the correlations of the 
inflationary responses observed in the mouse (Figure  3A), a 
relationship was observed between the magnitude of the HCMV-
specific CD8+ T cell response and the frequency of specific CD8+ 
T cells harboring an EM phenotype (Figure 3D). Remarkably, 
the development of the EM phenotype of CD8+ T cells against 
HCMV pp65 follows analogous kinetics upon primary infection 
of HCMV-seronegative patients receiving a HCMV-positive 
kidney transplant as compared to the EM phenotype of the 
inflationary MCMV epitopes (Figures  2B and 3E). Together, 
these data indicate that CD8+ T  cell responses against viral 
epitopes in HCMV and MCMV follow a similar developmental 
pathway in which the EM phenotype of the responding CD8+ 
T cells correlate with the magnitude of the viral-specific CD8+ 
T cell response.
Progressive eM cD8+ T cell  
Differentiation is accelerated  
by high-Dose cMV infection
To gain a more detailed understanding of the phenotypic 
differences of the MCMV-specific CD8+ T  cells that develop 
during the low, intermediate, and high-dose infection, we 
used a novel analysis platform, termed Cytosplore (34), for 
immune cell phenotyping that incorporates approximated 
t-distributed stochastic neighborhood embedding (A-tSNE) 
for dimensionality reduction and—the mean—shift clustering 
algorithm for subset definition, based on the dimensionality 
reduced data (37). The A-tSNE algorithm lays out cells in a 
two-dimensional scatter plot, based on similarity of defined 
markers. Similar cells will be placed closed together in the 
plot, while slight variations in the level of marker expression 
will result in gradual positional transitions. The results of the 
FigUre 3 | Correlations between the magnitude and phenotype of inflationary CMV-specific T cells. (a) Wild-type (WT) mice were infected with 103, 104 or 105 PFU 
mouse CMV (MCMV)-Smith. The percentage of MCMV-specific EM (CD44highCD62L−KLRG1+) CD8+ T cells versus the percentage of MCMV-specific CD8+ T cells in 
blood at day 300 post-infection. Data were pooled from two independent experiments. (B) WT mice were infected with 5 × 104 PFU MCMV-Smith once (n = 20) or 
weekly (n = 7) for 1 year. At 1 year post-infection, the average frequencies and phenotype of IE3-specific CD8+ T cells in blood was determined by MHC class I 
tetramer staining. The graph shows the percentage of IE3-specific EM (CD44highCD62L−KLRG1+) CD8+ T cells versus the percentage of IE3-specific CD8+ T cells in 
blood. (c) WT mice were infected with recombinant vaccinia virus expressing IE1 (VACV-IE1). At day 200 post-infection, the average frequencies and phenotype of 
IE1-specific CD8+ T cells in blood was determined by MHC class I tetramer staining. The graph shows the percentage of IE1-specific EM (CD44highCD62L−KLRG1+) 
CD8+ T cells versus the percentage of IE1-specific CD8+ T cells in blood (n = 18). (D) Analysis of human cytomegalovirus (HCMV)-specific CD8+ T cell responses. 
The percentage of antigen-specific EM CD8+ T cells versus the percentage of antigen-specific CD8+ T cells in blood from healthy donors for HCMV pp65 (n = 46). 
(e) The percentage of antigen-specific EM CD8+ T in blood from initially HCMV-seronegative recipients receiving a HCMV-positive kidney transplant against the 
weeks after transplantation.
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A-tSNE algorithm are then visualized as density plots. This 
provides an unprecedented insight into the development of the 
cellular differentiation, which is not feasible by conventional 
flow cytometry data analysis. We performed Cytosplore analy-
sis on the MCMV-specific CD8+ T cell populations we tracked 
in time by MHC class I tetramer staining combined with 
phenotypical markers comprising CD62L, KLRG1, CD27, and 
CD44, which allow discrimination between CM- and EM-type 
T cells (Figure S2A in Supplementary Material). Such analysis 
should display the potential differentiation trajectory path of 
EM- and CM-type T cells. In order to provide an initial global 
picture of the impact of CMV infection on the EM/CM T cell 
differentiation, we analyzed each MCMV-specific CD8+ T cell 
population in time using the combined data from the different 
infection dosages. We observed that the development of the 
EM phenotype of the inflationary T cells is progressive in time, 
as evidenced by an ongoing shift toward a higher advanced 
EM phenotype (indicated with red arrows) (Figure 4A). Even 
between days 120 and 200, the EM differentiation continues. 
To assess the role of dosing in this phenomenon, we performed 
the analysis with the separate dosages. Compared to low-dose 
infection, higher dose infections accelerated the EM CD8+ 
T  cell differentiation throughout the infection (Figure  4B, 
shown for IE3; Figure S2B in Supplementary Material, shown 
for M38). We also observed that the impact of the dosage 
effect on the EM CD8+ T cell differentiation is irrespective of 
the infection duration (Figure S3 in Supplementary Material). 
Together these data suggest that high-dose infection causes an 
EM CD8+ T cell differentiation that not only develops faster but 
also continues to segregate throughout the life span of the host, 
suggesting a virus–host equilibrium that is influenced by aging 
and the infectious dose.
The Dichotomy in cytokine 
Polyfunctionality of inflationary versus 
non-inflationary cMV-specific T cells 
increases with the infectious Dose
In elderly individuals, a higher frequency of cytokine-deficient 
CD8+ T cells recognizing the HCMV epitope pp65 is associated 
with all-cause mortality in these individuals, suggesting that 
the presence of these cells could predict age-related dysfunc-
tion and increased risk of death (38). To gain insight into the 
cytokine profile of the MCMV-specific T cells in differentially 
inoculated aged mice, we assessed the polyfunctional cytokine 
profiles 400  days after MCMV infection. The majority of the 
M45-specific CD8+ T  cell pool in the spleen comprises the 
capacity to coproduce IFN-γ, TNF, and IL-2 (Figure 5A). The 
frequency of these triple cytokine producers is elevated in mice 
infected with higher inoculums of MCMV. By contrast, CD8+ 
T cell populations specific for the inflationary epitopes (m139, 
M38, and IE3), consist most frequently of double-producing 
FigUre 4 | Progressive effector-memory (EM) CD8+ T cell differentiation is accelerated by high-dose CMV infection. Wild-type (WT) mice were infected with 103, 
104, or 105 PFU mouse CMV (MCMV)-Smith. MCMV-specific CD8+ T cells in blood were stained with MHC class I tetramers combined with cell surface markers 
(CD62L, KLRG1, CD27, and CD44) at the indicated time points post-infection. (a) Cytosplore analysis of the MCMV-specific CD8+ T cells in time. A-tSNE plots 
depict the pooled phenotypical data of MCMV-specific CD8+ T cells of the 103, 104, and 105 PFU MCMV-infected mice for each time point after infection. (B) A-tSNE 
plots depict the phenotype of the IE3-specific CD8+ T cell response of the 103, 104, and 105 PFU MCMV-infected mice for each time point after infection (n = 16 
mice per MCMV dose). Data were pooled from two independent experiments. In the A-tSNE plots, the differentiation path from the CM and EM phenotype is 
specified. The red arrows indicate the ongoing shift toward a higher advanced EM phenotype.
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cells (IFN-γ and TNF). These frequencies increase with higher 
MCMV inoculum dosages, while this coincides with decreas-
ing frequencies of triple cytokine producing cells (Figure 5A). 
Correspondingly, high-dose infection results in elevated 
absolute numbers of double IFN-γ/TNF producers, especially 
among the inflationary CD8+ T  cells (Figure  5B). In the 
MCMV-specific CD4+ T  cell pool a dose-dependent increase 
of double cytokine producers is also observed, although mainly 
at the expense of the single IFN-γ-producing cells (Figure S4A 
in Supplementary Material). Thus, whereas non-inflationary 
CD8+ T  cells have an increment of the most polyfunctional 
T cells with higher inoculums, inflationary CD8+ T cells tend 
to lose this property.
Only high-Dose cMV infection  
impairs the Development of  
heterologous T cell responses
To assess whether the initial infectious dosages that determine 
the degree of the CMV-induced perturbations of peripheral 
FigUre 5 | The dichotomy in cytokine polyfunctionality of inflationary versus non-inflationary CMV-specific T cells increases with the infectious dose. Following 
mouse CMV (MCMV) infection with different dosages (103, 104, or 105 PFU MCMV-Smith), the cytokine polyfunctionality of splenic CD8+ T cells was determined after 
peptide restimulation at day 400 post-infection. (a) Pie charts depict the percentages of the single (IFN-γ), double (IFN-γ/TNF), and triple (IFN-γ/TNF/IL-2) cytokine 
producers of each antigen-specific T cell population upon peptide stimulation. (B) Absolute counts of the single (IFN-γ), double (IFN-γ/TNF), and triple (IFN-γ/TNF/
IL-2) cytokine producers of each antigen-specific T cell population upon peptide stimulation. Data represents mean values (n = 8 per group). Data were pooled from 
two independent experiments.
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naive and memory T cell compartments is connected to differ-
ential impairment of the development of heterologous anti-viral 
immunity, we challenged 400-day-old naive and MCMV-
infected mice (1 × 103, 1 × 104, or 1 × 105 PFU MCMV) with 
2 × 105 PFU LCMV-Armstrong. LCMV infection significantly 
increased the absolute splenic CD8+ T cell numbers of the naïve 
mice and of the mice infected with 1  ×  103 or 1  ×  104 PFU 
MCMV compared to age-matched mice that did not receive 
a LCMV challenge (Figure  6A). Strikingly, in mice that were 
long-term infected with the highest dose of MCMV (1  ×  105 
PFU), the LCMV-induced CD8+ T cell expansion was impaired 
and numbers were not significantly increased (Figure  6A). 
Determination of the effector CD8+ T cell quantities revealed 
a similar trend; albeit LCMV challenge caused a significant 
increase in all groups, the expansion was least pronounced when 
mice were previously infected with the highest dose of MCMV 
(Figure  6B), suggesting a reduction in LCMV-specific CD8+ 
T  cells when mice experienced high-dose MCMV inoculums 
previously. To test this assumption, we determined absolute 
numbers of LCMV-specific (GP3333–41, NP396–404, and GP276–286) 
CD8+ T cells by MHC class I tetramer binding (Figure 6C), and 
found indeed that the response against these immunodominant 
LCMV epitopes was mostly reduced in mice that were inoculated 
with the highest dose of MCMV (1 × 105 PFU). Analysis of the 
LCMV-specific CD4+ T cell response (GP61–80) as measured by 
IFN-γ production revealed no MCMV-induced perturbations 
(Figures S4B,C in Supplementary Material). Together, these data 
suggest that high-dose MCMV infection affects the capacity of 
immunodominant CD8+ T cells to expand upon heterologous 
infections.
To assess whether the increasing doses of MCMV could dif-
ferentially affect the activation status of the LCMV-primed CD8+ 
T cells, the cell surface expression of CD27, CD127, CD62L, and 
KLRG1 was evaluated. Strikingly, we found that the frequency 
of the immunodominant LCMV-specific CD8+ T cells express-
ing CD27, and correspondingly the expression of CD27 on a 
per cell basis, was mostly reduced in mice persistently infected 
with the highest MCMV dose (Figures 6D,E), while expression 
of CD127, CD62L, and KLRG1 was not influenced by MCMV 
infection (Figures S5A–C in Supplementary Material). Next, 
FigUre 6 | High-dose CMV infection impairs the development of heterologous viral-specific T cell responses. (a–e) Wild-type (WT) mice were kept uninfected  
or infected with 103, 104, or 105 PFU mouse CMV (MCMV)-Smith (n = 16 mice per group), and at day 400 post-infection 8 mice per group were challenged with 
2 × 105 PFU lymphocytic choriomeningitis virus (LCMV)-Armstrong. At day 8 post LCMV infection, mice were analyzed and compared with uninfected littermate 
controls. (a) Numbers of total splenic CD8+ T cells. (B) Numbers of total effector (CD44highCD62L− KLRG1+) CD8+ T cells. (c) Numbers of splenic LCMV-specific 
CD8+ T cells determined by MHC class I tetramer staining. (D) Percentage of LCMV-specific CD8+ T cells expressing CD27. (e) Mean fluorescence intensity (MFI)  
of CD27 expression on LCMV-specific CD8+ T cells. (F,g) WT mice were kept uninfected or infected with or 105 PFU MCMV-Smith (n = 8 mice per group), and at 
day 90 post-infection challenged with 2 × 105 PFU LCMV-Armstrong. At day 8 post LCMV infection, mice were analyzed and compared with uninfected littermate 
controls. (F) Numbers of splenic LCMV-specific CD8+ T cells determined by MHC class I tetramer staining. (g) Percentage of LCMV-specific CD8+ T cells 
expressing CD27. Results are represented as means and error bars indicate SEM (n = 8 mice per group). *P < 0.05; **P < 0.01; ***P < 0.001. Data were  
pooled from two independent experiments.
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FigUre 7 | High-dose CMV infection impairs the autocrine IL-2 production of heterologous viral-specific T cells. Wild-type (WT) mice were kept uninfected or 
infected with 103, 104, or 105 PFU mouse CMV (MCMV)-Smith, and at day 400 post-infection 8 mice per group were challenged with 2 × 105 PFU lymphocytic 
choriomeningitis virus (LCMV)-Armstrong. At day 8 post LCMV infection, mice were analyzed and compared with uninfected littermate controls. (a) The cytokine 
polyfunctionality of splenic CD8+ T cells was determined after peptide restimulation. Pie charts depict the percentages of the single (IFN-γ), double (IFN-γ/TNF), and 
triple (IFN-γ/TNF/IL-2) cytokine producers of each antigen-specific T cell population upon peptide stimulation. (B) MFI of IL-2 expression of LCMV-specific CD8+ 
T cells. All data represents mean values + SEM (n = 8 per group, *P < 0.05). Data were pooled from two independent experiments.
10
Redeker et al. High-Dose CMV Provokes Immune Senescence
Frontiers in Immunology | www.frontiersin.org January 2018 | Volume 8 | Article 1953
we investigated if the impairment of heterologous immune 
responses due to high-dose CMV infection is related to long-
term infection of aged mice. Strikingly, the LCMV-specific 
CD8+ T cell response in young mice (5 months old) that were 
previously uninfected or infected with a high-dose MCMV 
(1 × 105 PFU MCMV-Smith) revealed no reduction or even an 
increase in the amount or activation status of LCMV-specific 
CD8+ T cells (Figures 6F,G; Figure S5D–G in Supplementary 
Material).
Next, we aimed to determine if the MCMV dose-associated 
alterations could also impact the cytokine polyfunctionality of 
the LCMV-specific CD8+ T cell responses in the aged MCMV-
infected mice after heterologous infection with LCMV. Following 
ex vivo stimulation with class I-restricted peptides GP33–41, NP396–
404, and GP276–286, the frequencies of the single (IFN-γ), double 
(IFN-γ and TNF), and triple (IFN-γ, TNF, and IL-2) producing 
LCMV-specific CD8+ T cells were determined. Although an obvi-
ous altered cytokine profile was not detected (Figure  7A), the 
responding LCMV-specific T cells exhibited a lower IL-2 expres-
sion on a per cell basis in only those mice that were previously 
inoculated with the highest dose of MCMV (Figure 7B). Analysis 
of the CD4+ T cell response against the LCMV epitope GP61–80 
showed that the cytokine polyfunctionality of the LCMV-specific 
CD4+ T cells are not affected by lifelong MCMV infection (Figure 
S4B in Supplementary Material).
Taken together, these results establish that persistent MCMV 
infection induced by a high inoculum dose is able to decrease the 
development of heterologous adaptive immune responses upon 
encountering a new pathogen.
The inflammatory Milieu and antibody 
levels upon heterologous infection  
are influenced by the inoculum Dose  
of McMV
Chronic low grade inflammation accompanied with persistent 
CMV infection might affect antigen-presenting cells in such 
a way that the priming of T  cells against newly encountered 
antigens is hampered. To test whether the size of the inoculum 
dose might influence low grade inflammation in steady state 
FigUre 8 | The inflammatory milieu and antibody levels upon heterologous infection are shaped by the inoculum dose of mouse CMV (MCMV). (a–e) Wild-type 
(WT) mice were kept uninfected or infected with 103, 104, or 105 PFU MCMV-Smith (n = 16 mice per group), and at day 400 post-infection 8 mice per group were 
challenged with 2 × 105 PFU lymphocytic choriomeningitis virus (LCMV)-Armstrong. At day 8 post LCMV infection, mice were analyzed and compared with 
uninfected littermate controls. Cytokines and chemokines in the serum were determined by mouse cytokine bio-plex immunoassays (a–c), and MCMV (D) or 
LCMV-specific (e,F) antibody levels were determined by ELISA. (a–c) Shown are the serum concentrations of IFN-γ (a), TNF (B), and IL-2 (D). MCMV-specific IgG 
antibody levels in LCMV unchallenged mice (e) Levels of LCMV-specific IgM antibodies in LCMV-challenged mice. (F) WT mice were kept uninfected or infected 
with 105 PFU MCMV-Smith, and at day 90 post-infection mice were challenged with 2 × 105 PFU LCMV-Armstrong. Blood was taken 8 days after LCMV infection 
and levels of LCMV-specific IgM antibodies within the serum were determined. Data represents mean values + SEM (n = 8 per group, *P < 0.05). Data were pooled 
from two independent experiments.
11
Redeker et al. High-Dose CMV Provokes Immune Senescence
Frontiers in Immunology | www.frontiersin.org January 2018 | Volume 8 | Article 1953
and upon heterologous infection, we determined cytokine and 
chemokine serum levels. Analysis of the tested cytokine and 
chemokine levels revealed no substantial changes between 
mice that were infected with different doses of MCMV at 
day 400 post MCMV infection (Figure S6 in Supplementary 
Material). Upon LCMV infection, we observed for a number 
of cytokines/chemokines a major increase, albeit mostly this 
was not influenced by the MCMV inoculum dose. However, 
a MCMV dose-dependent decrease in IFN-γ serum levels is 
apparent (Figure 8A). For the TNF serum levels the same trend 
was observed (Figure 8B). Analysis of the IL-2 serum concen-
tration revealed that IL-2 levels were lower in the high MCMV 
dose inoculating mice (Figure 8C), which corresponds to the 
lower amounts of IL-2 produced by the inflationary T cells. In 
contrast to the other cytokines present in serum, upon LCMV 
infection the IL-2 levels decreased in the mice without prior 
MCMV infection and in the mice inoculated with 1  ×  103 
and 1  ×  104 PFU. Whereas in mice that experienced lifelong 
infection with the highest MCMV dose, the IL-2 concentra-
tion increased, suggesting a lower rate of IL-2 consumption 
by the T  cells (Figure  8C). Thus, the MCMV inoculum dose 
differentially shapes the inflammatory milieu with respect to 
effector T  cell-associated cytokines (IFN-γ, TNF, IL-2) upon 
encountering a new pathogen.
Given the correlation between MCMV-specific antibody 
titers and the infectious dose (Figure 8D), we aimed to address 
whether the MCMV inoculum dosage particularly affects het-
erologous T cell responses or whether also heterologous B cell 
responses are influenced. In the MCMV-infected mice 8  days 
after LCMV infection the LCMV-specific IgM antibody induc-
tion was hampered and only in those mice that were previously 
inoculated with high-dose MCMV (Figure 8E). In young mice 
with and without a latent MCMV infection that were challenged 
with LCMV a reverse trend was observed. In these mice the 
LCMV-specific IgM production was increased in mice with a 
latent MCMV infection (Figure 8F). Thus, only in aged mice the 
MCMV inoculum size inversely correlates with LCMV-specific 
IgM induction after heterologous infection.
high-Dose cMV infection hampers 
control of heterologous infections and 
correlates to the Phenotypical alterations 
of Virus-specific cD8+ T cells
To determine if the aforementioned MCMV-induced immune 
alterations resulted in hampered LCMV control, we determined 
the LCMV viral load in the lungs and kidneys of the uninfected 
and MCMV-infected mice. We observed that compared to 
FigUre 9 | High-dose CMV infection hampers control of heterologous infections and correlates to the phenotypical alterations of virus-specific CD8+ T cells. (a) 
Wild-type (WT) mice were kept uninfected or infected with 103, 104, or 105 PFU mouse CMV (MCMV)-Smith (n = 16 mice per group), and at day 400 post-infection 8 
mice per group were challenged with 2 × 105 PFU lymphocytic choriomeningitis virus (LCMV)-Armstrong. At day 8 post LCMV infection, mice were analyzed for the 
LCMV viral load in lungs and kidneys. (B) WT mice were kept uninfected or infected with or 105 PFU MCMV-Smith (n = 8 mice per group), and at day 90 post-
infection challenged with 2 × 105 PFU LCMV-Armstrong. At day 8 post LCMV infection, mice were analyzed for the LCMV viral load. (a,B) All data represents mean 
values + SEM (n = 8 per group). n.s. P > 0.05; * P < 0.05; ** P < 0.01. (c–D) Correlation between lung LCMV titers and the frequency of peripheral effector-
memory (EM) (c) and central-memory (CM) (D) CD8+ T cells 400 days post-infection of the same mice. Pearson’s correlations were used to determine the strength 
of the correlations ****P < 0.0001. Data were pooled from two independent experiments.
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MCMV-naive mice the viral load was significantly increased in 
mice that were inoculated with 1 × 105 PFU MCMV. Importantly, 
in mice that were inoculated with lower doses of MCMV, control 
of LCMV replication was not significantly affected (Figure 9A). 
Importantly in young mice inoculated with a high-dose, LCMV 
infection was even slightly better controlled (Figure 9B).
The frequency of EM T cells in peripheral blood of aged mice 
correlates with the inoculum dose while an inverse correlation is 
seen for CM CD8+ T cells. To determine whether the frequency 
of EM CD8+ T cells before challenge with LCMV also correlates 
with the ability to control heterologous infection, we plotted 
the EM frequencies of the total CD8+ T cell population against 
the LCMV viral load in the lungs. Clearly, a strong connection 
between the EM phenotype and LCMV titers in the lungs is 
observed (Figure  9C). A reverse correlation was found when 
the frequency of CM T cells was plotted (Figure 9D). These data 
indicate that the frequency of EM CD8+ T  cells (or inversely 
the CM CD8+ T cells) can be used as predictors of a possible 
defective capacity of the host to respond to newly encountered 
pathogens.
DiscUssiOn
The possible contribution of CMV to immune senescence has 
received considerable attention but remained controversial 
(20, 21). To extend our knowledge with respect to the role of 
CMV in immune senescence, we performed a highly controlled 
prospective study revealing that the size of the initial viral inoc-
ulum dictates the degree of CMV-induced immune alterations 
in long-lasting infection. Our data revealed a clear correlation 
between the magnitude of the CD8+ T  cell response and the 
frequency of CMV-specific CD8+ T cells exhibiting an EM phe-
notype, which was apparent in CMV-infected mice and humans. 
Importantly, we show that solely a high CMV infectious dose 
results in immune perturbations that are substantial enough 
to impair heterologous anti-viral immunity, thereby providing 
a better understanding of CMV in immune senescence and in 
addition settles previous controversies in this respect.
In agreement with our results, several studies have shown that 
MCMV infection with a high infectious dose causes immune per-
turbations that impair CD8+ T cell immunity later in life (22–24). 
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Previously, we have shown that the influence of CMV on eliciting 
inflationary EM-like CD8+ T cells populations is depending on 
the inoculum dose (27). In the current study, we have appreci-
ated this differential impact of dissimilar CMV dosages and 
show that CMV infection does not by definition impairs immu-
nity, but specifically a high infectious dose is a prerequisite for 
CMV-associated immune senescence. Conceivably, in immune 
compromised hosts where viral control is hampered, already a 
low viral dose might result in CMV-related immune senescence. 
Although we have shown that weekly reinfection with the same 
dose does not increase EM T cell accumulation, it should be noted 
that in addition to the initial infectious dose, the CMV dosage 
during reinfection and the level of pre-existing CMV-specific 
neutralizing antibodies could impact the degree of CD8+ T cell 
accumulation. We assume that in humans, where reinfection is 
known to occur (39), the viral dose differs in subsequent reinfec-
tion. We consider it likely that CMV reinfection with increasing 
infectious doses does intensify the degree of EM T cell accumula-
tion and, hence, thereby possibly immune senescence.
In human individuals, correlations between HCMV positivity 
and impaired immunity are controversial since this relationship 
is observed in some but not all studies (12–18, 40–44). Our 
results can at least partly explain this controversy, because it is 
highly conceivable that in humans CMV infection occurs with 
infectious dosages that are highly variable. In addition, besides 
the infectious dose also host intrinsic factors such as genetic 
predisposition can impact the CMV grade, and hence, contribute 
possibly to immune senescence.
The accumulation of CMV-specific EM CD8+ T cells, which 
correlate with impaired heterologous immunity, might by itself be 
(partly) causative for the negative impact of long-standing latent 
CMV on heterologous immunity. In case of high-dose infection, 
the frequency of CMV-specific CD8+ T cells might reach a certain 
threshold resulting in diminished priming of naive T cells against 
newly encountered pathogens. Indeed, detailed cluster analysis 
of the EM development of the circulating CMV-specific CD8+ 
T cells showed that high-dose infection causes a differentiation 
pathway that progresses faster throughout the life span of the host, 
suggesting a virus–host equilibrium that is not fixed and appar-
ently is influenced by aging and the infectious dose. Whether 
ongoing EM differentiation takes also place in tissues requires 
further investigations. A higher infectious dose is known to result 
in a higher level of reactivation from latency (45) and this is in 
line with the observation that a higher CMV dose results in larger 
reservoirs of latent CMV (27). As a result, stimulation of CMV-
specific T cells is increased, thereby accelerating differentiation. 
Moreover, we observed that the LCMV-specific CD8+ T cells in 
mice infected with a high CMV dose are not properly primed 
as evidenced by decreased upregulation of CD27 and lower IL-2 
production. It is considered that in aged individuals priming 
occurs less as compared to young (46). The additional amounts 
of (activated) T cells might further diminish this by competing 
for T  cell growth factors or even by competition at the APC 
level. Nonetheless, we consider it likely that the accumulation 
of CMV-specific T  cells is not solely responsible for impairing 
immune responses against newly encountered pathogens. For 
example, our analysis also revealed a weakened LCMV-specific 
B cell response in those mice that were infected with the highest 
dose of MCMV. In mouse and human CMV infection, accumula-
tion of CMV-specific antibodies has been reported (27, 47, 48). 
This may indicate that also accumulation of CMV-specific 
antibody-producing B cells occurs. Possibly these CMV-specific 
plasma cells compete with B cells that are specific for the newly 
encountered pathogen.
In contrast to what we observed in aged mice, in young 
mice CMV infection seems to improve immunity against other 
pathogens, which is in agreement with other reports showing 
beneficial effects of herpesvirus infection on protection from 
other infections (18, 49). However, the positive effects of 
herpesvirus infections in young mice is transient (18, 49, 50), 
which may be due to a temporary effect on both the innate and 
adaptive immune system. In addition, Furman et  al. showed 
that CMV-seropositive young adults displayed an increase in 
CD8+ T  cell sensitivity and an improvement in the antibody 
response upon influenza vaccination, and it was shown that 
IFN-γ was required for the CMV-associated improved cross-
protection (18). Upon heterologous challenge with LCMV, we 
observed that serum levels of IFN-γ were significantly reduced 
in mice that were infected with the highest dose of CMV 
compared to mice that were CMV negative. This suggests that 
a “fit” immune system in which IFN-γ production is properly 
induced is crucial for the CMV-associated enhancement of 
heterologous immune responses. We consider it likely that 
aging by itself abolishes the positive effect of CMV by decreas-
ing the IFN-γ-producing capacity and that a combination of 
old age and extensive CMV-induced immune aberrations shift 
the balance toward a negative effect of CMV on heterologous 
immunity.
In summary, our results demonstrate that the infectious dose 
of CMV is a key determinant for the immunological outcome 
and consequently, also projects the possible impact for heter-
ologous immunity later in life. Importantly, here we show for 
the first time that only infection with a high CMV infectious 
dose impairs the immune response against newly encountered 
pathogens in aged hosts. Thus, reduction of the latent/lytic 
viral load (by anti-viral drugs or vaccination) can be beneficial 
to diminish CMV-associated immune senescence. Future 
prospective longitudinal studies that incorporate stratification 
based on the strength of the HCMV-specific immune response 
are required to further delineate the contribution of CMV to 
immune senescence.
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